Cannabinoids, CBD, THCV, CBG, Inflammation, Brain Injury, Diabetes, Gut Health & Academia vs. Industry | Saoirse O'Sullivan | 41
Mind & Matter
00:00
The Future of Cannabinoid Research
There's an awful lot of stuff that's kind of at phase two, you know, so still small clinical trials not quite moving forward to potential licensing. So I think we will see a change in the next kind of three to five years in terms of what's available for licensed cannabinoid based medicines. But from a commercial point of view, it's not patentable. People aren't investing the kind of money to do big trials in that type of research. The short term future is going to be more specific and patented products in terms of the therapeutic use of cannabis-based medicines.
Play episode from 01:18:49
Transcript
